Dr. Jerry Callahan brings 15 years of operational leadership experience in developing businesses in environments of change, and he has held numerous executive positions in traditional start-up ventures, as well as successfully leading start-up initiatives within existing organizations. Dr. Callahan serves on the boards of several private equity and venture capital organizations focused on the life sciences and has held executive level positions in the education, research, nutrition, and life science industries.
Dr. Callahan is a Director of Hopen Life Science Ventures, a Grand Rapids-based venture capital fund formed to take advantage of converging market dynamics in the life science field. There he is responsible for human resources, business and organizational development, and finance. He also serves as a Vice President of Business Development and Strategic Projects to the Van Andel Institute, where his responsibilities include establishing internal commercialization processes to ensure efficient and effective transition of innovative technologies from laboratory to marketplace. In addition, Dr. Callahan is founder and launch CEO for Intervention Insights, a personalized medicine company serving the community oncology market. Before this, he was chief information officer and vice president of supply chain at Twinlab Corporation, where he played a key role in the company’s growth through acquisitions and new product launches. In 2004, he co-founded Hope River Ventures, Inc., a Grand Rapids-based private equity investment company focused on the life sciences sector.
Dr. Callahan has a BS from University of Illinois in Business Administration, MBA from Western Michigan University, an MS from Ferris State University in information technology, and a PhD in organizational design from Union Institute & University.